	Managing Close and Involved Margins Following Excision of Non-Melanoma Skin Cancer: A Retrospective Cohort Study. Australas J Dermatol Matheus IG, Wagels M. PMID: 41730679 [PubMed - as supplied by publisher]
	Lifestyle Medicine Strategies for Reducing Risk of Melanoma: Modifiable Factors and Clinical Implications. Am J Lifestyle Med Alaswad L, Galiatsatos P, Srivastava G. PMID: 41727279 [PubMed - as supplied by publisher]
	31-Gene expression profiling for cutaneous melanoma: an expert consensus panel. Dermatol Online J Burshtein J, Cockerell C, Cotter D, Farberg A, Ferris L, Kaufmann M, Leachman S, Rizzo J, Schlesinger T, Shah M, DeBusk L, Rosenberg A, Bartley B, Lebwohl M, Rigel D. PMID: 41725468 [PubMed - indexed for MEDLINE]
	Endâ€‘ofâ€‘life care in advanced melanoma: a retrospective cohort study from an Italian comprehensive cancer center. BMC Cancer De Mattia M, Boutros A, Delucchi V, Blondeaux E, Lambertini M, Lagodin D'Amato A, Giannubilo I, Del Mastro L, Pronzato P, Bighin C, Spagnolo F, Tanda ET. PMID: 41723391 [PubMed - as supplied by publisher]
	Gut microbial signatures and immunotherapy outcomes in NSCLC and melanoma: a systematic review and meta-analysis. BMC Cancer Essa MEA, Noori H, Butler J, Ahmed AA. PMID: 41723389 [PubMed - as supplied by publisher]
	Clinical impact of butterbur shoot extract in dogs with oral melanoma: a combined phase 1 and 2 clinical trial. BMC Vet Res Noguchi S, Furuya M, Honda K, Ito R, Akao Y. PMID: 41721401 [PubMed - as supplied by publisher]
	Prognostic significance and clinicopathological association of tumor budding and poorly differentiated clusters in cutaneous malignant melanoma. Virchows Arch Xie YL, He S, Rehman S, Lu SY, Ke LF, Zhang WW, Chen Y, Chen G, Chen YP. PMID: 41718769 [PubMed - as supplied by publisher]
	Natural compounds as immune checkpoint inhibitors in melanoma: a systematic review. Naunyn Schmiedebergs Arch Pharmacol Samieefar S, Arasteh O, Yeganeh Khorasanii N, Abedi F, Hosseinzadeh HR, Hosseinzadeh H. PMID: 41718747 [PubMed - as supplied by publisher]
	Does tumor-infiltrating lymphocyte therapy improve survival outcomes in patients with advanced melanoma? Front Med (Lausanne) Ridley-Parish P. PMID: 41716797 [PubMed]
	Oral amelanotic melanoma in a 73-year-old patient: A rare case report and literature review. J Clin Exp Dent de Arruda JA, Drumond VZ, Abreu LG, de Cáceres CV, Vargas PA, Caldeira PC, Fonseca FP, Mesquita RA, de Andrade BA, Silva TA. PMID: 41716371 [PubMed]
	Impact of adjuvant anti-PD-1 immunotherapy on ovarian function in female patients with resectable melanoma: A prospective observational study. Eur J Cancer Pedersen S, Colmorn LB, Ellebaek E, Kristensen SG, Ruhlmann C, Borch TH, Donia M, Fedder J, Macklon KT, Svane IM. PMID: 41713079 [PubMed - as supplied by publisher]
	Cutaneous melanoma histopathologic features and laboratory findings as predictors of sentinel lymph node status and progression-free survival: a single-center experience. Acta Dermatovenerol Alp Pannonica Adriat Panti, Pantovi, Kotur M, Petri, Radivojevi, Petrovi, Vujo, Gruji, Grozdi, , Artiko V, Odalovi. PMID: 41712199 [PubMed - indexed for MEDLINE]
	Correction to "Advances in the noninvasive diagnosis of melanoma-40 years beyond the ABCDs". CA Cancer J Clin PMID: 41711686 [PubMed - in process]
	SWE-NEO: Swedish NEO-adjuvant trial comparing anti-PD-1 monotherapy to combined anti-CTLA-4/anti-PD-1 blockade in resectable stage III melanoma: study protocol for a phase III open-label multi-centre trial. Acta Oncol Helgadottir H, Carneiro A, Portelli F, Papadakis K, Björkström K, Yang M, Johansson I, Skogvall Svensson I, Jazrawi A, Hallgren A, Harbst K, Bark R, Egyhazi Brage S, Berglund A, Isaksson K, Wickström S, Nilsson J, Ny L, Jönsson G, Olofsson Bagge R, SWE-NEO Study Group. PMID: 41711492 [PubMed - in process]
	Rational Design and Responsive Transdermal Cargo Delivery of Microneedles in the Treatment of Melanoma. Int J Nanomedicine Cai M, Jia Y, Fu T, Kong J, Qiu Y, Zhao Y, Li X, Yang Y, Bai D. PMID: 41710366 [PubMed - indexed for MEDLINE]
	Effective inhibition of lung metastatic melanoma by pH-responsive lipopeptide/PLGA hybrid nanoparticles silencing PD-L1 with augmented suppression of the AKT/Î²-catenin pathway. J Mater Chem B Yang Z, Wang S, Song Z, Guo R, Ding D, Gao Y, Qiao M. PMID: 41709848 [PubMed - as supplied by publisher]
	Tumour-infiltrating lymphocyte therapy in melanoma: ready for prime time? Br J Cancer Woodford R, Lorigan P, Oudit D, Abdulgawad A, Thistlethwaite F, Lim KHJ. PMID: 41708938 [PubMed - as supplied by publisher]
	Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB): A Translational Pharmacodynamic Biomarker for PIKfyve Inhibition With VRG50635. Clin Transl Sci Gontier G, Kim G, Wang C, Zhu K, Gau R, Zhang N, Naphade S, Stewart A, Schmidt MJ, Galemmo R, Shook B, Tarachandani A, Choi I, Raines S, Scannevin RH, Grievink HW, Smits LMG, Kremer PHC, Cadavid D. PMID: 41708347 [PubMed - indexed for MEDLINE]
	Tumor necrosis alpha inhibitor therapy is associated with increased long-term risk of non-melanoma skin cancer and melanoma: a retrospective cohort study. J Am Acad Dermatol Driscoll CB, Schwab G, Quan VL, McKenney J, Hooper MJ, Shankar Ramesh Kumar SK, Kundu RV, Kundu SD. PMID: 41707711 [PubMed - as supplied by publisher]
	Integrated LIBS-Raman spectroscopy coupled with explainable machine learning for biochemical characterization of melanoma. Spectrochim Acta A Mol Biomol Spectrosc Khan MN, Zhou Q, Guo J, Liu L, Hu R. PMID: 41707627 [PubMed - as supplied by publisher]

Articles 1 - 20 / 45191

Page 1 of 2260



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy